In a very latest research, we reported the identification as well as the characterization of a different atypical opioid receptor with special damaging regulatory Houses in direction of opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a wide-spec